Europe’s leading MedTech investment series continued last week with the 16th MedTech Investing Europe Conference taking place 25-26 April at the MCH Beaulieu Lausanne, Switzerland.
The event welcomed a record number of Presenting Companies who showcased investment opportunities in their ground-breaking technologies to an audience of investors and MedTech professionals representing over 16 countries both from Europe and beyond.
The finely-tuned conference programme brought together highly experienced speakers including MedTech professionals from VC’s, private investors, major MedTech corporations and successful entrepreneurs. These panel sessions analysed the latest investment trends, recommendations for successful fundraising and investment strategies and gave an unrivalled look at where future opportunities will be coming from.
The free-to-attend workshop featured on Day 1 provided experienced investors and entrepreneurs as well as newcomers with tips and suggestions as to how to attract funding and successfully develop technology to meet today’s healthcare delivery demands.
The MTI team would like to thank all our sponsors, supporters and participants who made the event such a success.
We are delighted to announce the 17th MedTech Investing Europe Conference will be taking place 25-26 September at the King’s Fund London, UK. More detail will follow shortly.
|
|
|
Partners
Presenting companies
 120x120.jpg)
Associations
 120x 120.jpg)
 120x120.jpg)
Previous attendees comments
"Both the number of investors and their calibre proved unrivalled in what was a thoroughly enjoyable and productive conference"
"The recent session in London was terrific - well organized and efficient. It's clear that your meetings are playing an important role during a period when our industry is becoming even more global, and our capital markets are more cross-linked than ever before."
"We found the event very valuable and were very impressed with the calibre of the entrepreneurs and the good turn out from corporates and VCs too. A massive thank you from us"
"Less is more and a critical mass of interesting investors"